QhTnsX1EP84LeY3xZZND6V9mVp2oos6HjY5QCDAdrug $OMIPAL
The logic is roughly as follows: Omipalisib (GSK2126458) is a potent mTOR inhibitor, which was found to have significant lifespan-extending effects in a recent screening study conducted in 2024 by Epiterna, Rapamycin Longevity Lab, and Ora Biomedical using nematodes (Caenorhabditis elegans). It is reported that its effect on extending the lifespan of nematodes is more than twice that of the known longevity compound rapamycin.
@BioProtocol has a vote where the first place will buy 25 SOL, which should have a promotional effect at that time.
The results of RMR1 confirm that rapamycin should serve as the baseline for future combination interventions, while RMR2 is based on rapamycin with additional methods layered on top. RMR2 is the main work of @Aubrai_. This generation of $URO and $RIF.
Show original
1.6K
0
The content on this page is provided by third parties. Unless otherwise stated, OKX TR is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX TR. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX TR is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.